中/EN Contact/Message
  • Home
  • central pharmacy
  • Policies
  • Medical Institution
  • Franchise
  • Innovate
  • Recruit
  • News
  • Home
  • central pharmacy
  • Policies
  • Medical Institution
  • Franchise
  • Innovate
  • Recruit
  • News
  • 中/EN
  • Contact/Message
    • Innovate
    Your current position：
    Opdualag
    Opdualag
    departments：肿瘤科
    drug：注射剂
    Active：nivolumab and relatlimab-rmbw
    indication：治疗不可切除或转移性黑色素瘤
    Licensor：BMS
    Approved Country/Region：FDA
    Approval time：2022-03-18